-+ 0.00%
-+ 0.00%
-+ 0.00%

NuWays reiterates Buy on Eckert & Ziegler, sets price target at EUR 21.5

PUBT·08/14/2026 07:00:50
Listen to the news
NuWays reiterates Buy on Eckert & Ziegler, sets price target at EUR 21.5
  • NuWays reiterated a BUY rating on Eckert & Ziegler with a 12-month target price of EUR 21.5.
  • H1 adjusted EBIT rose 10% year-on-year excluding license income; margin widened 1.2 percentage points to 22.3%.
  • Medical segment drove results; adjusted EBIT jumped 35% excluding license income to EUR 24.9 million on 7% sales growth.
  • Isotope Products sales were flat at EUR 68.5 million; adjusted EBIT fell 24% to EUR 9.4 million on weaker mix.
  • NuWays kept FY26 guidance of about EUR 320 million sales, about EUR 80 million adjusted EBIT; cited sub-10x 2026e EV/EBIT valuation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief via EQS News (Ref. ID: rc_26538) on August 14, 2026, and is solely responsible for the information contained therein.